Industry
Bon Secours Mercy Health agrees to acquire Surgery Partners in $5.7 billion deal
Bon Secours Mercy Health agreed to acquire Surgery Partners in a deal valued at $5.7 billion.

The original reports on this story are listed below.
Industry
Bon Secours Mercy Health agreed to acquire Surgery Partners in a deal valued at $5.7 billion.

The original reports on this story are listed below.

Research
After surgery, adding the personalized vaccine to pembrolizumab reduced recurrence or death risk by 42%, but an overall survival benefit has not been shown.

Heart health
The framework asks clinicians to connect cardiovascular, hormonal and emotional health across four female life stages.

Research
In the phase III trial, divarasib reduced the risk of death by 44% compared with sotorasib or adagrasib.
This Week in Medicine
The most important medical news of the week, summarized for you and easy to read. Every Sunday, free.
Free. No spam. Unsubscribe anytime.